JACQUELINE MERRILL: Open Payments
NPI 1093316747 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 32 payments from 9 companies in 2025. Trend: 2023 $1,384 · 2024 $772 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 8 | $150 |
| Janssen Pharmaceuticals, Inc | 6 | $112 |
| Teva Pharmaceuticals USA, Inc. | 6 | $110 |
| Alkermes, Inc. | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| ABBVIE INC. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $15 |
Products named: INVEGA SUSTENNA, FANAPT, ARISTADA, UZEDY, COBENFY, HETLIOZ, AUSTEDO XR, ABILIFY ASIMTUFII.
Industry payments across KY — which companies pay providers there.
